Listeriosis, cutaneous A32.9

Author: Prof. Dr. med. Peter Altmeyer

All authors of this article

Last updated on: 25.04.2021

Dieser Artikel auf Deutsch

Synonym(s)

Cutaneous listeriosis

History
This section has been translated automatically.

Murray, 1926; the disease was named after the English surgeon Josef Baron Lister.

Definition
This section has been translated automatically.

Namely notifiable bacterial infectious disease with Listeria monocytogenes (direct pathogen detection from blood, cerebrospinal fluid and other substrates, as well as from smears from newborns) usually sporadic, occasionally epidemic. Basically, a distinction must be made between the different types of infection, as they present themselves under different clinical conditions.

Primary cutaneous listeriosis is a very rare zoonosis.

Pathogen
This section has been translated automatically.

facultatively pathogenic Listeria spp. (gram-positive, mobile, non-porous, catalase-positive, facultatively anaerobic rods). The most important human pathogenic species is Listeria monocytogenes, L. seeligeri or L. ivanovii are also rarely found in infected persons. About 10% of humans and animals are healthy intestinal carriers of Listeria monocytogenes. In immunocompetent people, infection does not occur.

Occurrence/Epidemiology
This section has been translated automatically.

Diseases are rare. In the Federal Republic of Germany: about 100-300 reported diseases/year.

Etiopathogenesis
This section has been translated automatically.

Smear infection on contact with sick animals, possibly through consumption of infected food, also by healthy germ carriers, in foetus diaplacental. Infected persons (even with asymptomatic courses) can excrete the pathogen via the stool for several months. In mothers of infected newborns, the pathogen is detectable in lochial secretions and urine about 7-14 days after delivery, rarely longer.

Manifestation
This section has been translated automatically.

Symptomatic disease mainly in patients with immune deficiency, e.g. newborns, old people, tumors, HIV infection, immunocompromised persons, transplanted persons, pregnant women.

No age or sex preference.

Localization
This section has been translated automatically.

In cutaneous inoculation listeriosis: hands and forearms

Clinical features
This section has been translated automatically.

Incubation period: 3-70 days

Listeriosis of the newborn: infection occurs transplacentally, during birth or postnatally through contact.

Postnatal listeriosis: in immunocompetent individuals, usually unnoticed asympotmatic or with mild gatrointestinal symptoms. In immunocompromised or those with consumptive disease, severe invasive courses with fever, headache, drowsiness, lumbar pain, meningitis and sepsis (granulomatosis infantiseptica). Skin may be involved in the setting of bacteremia due to vasculitic exanthema. 30% of septic listeriosis (mainly immunocompromised persons are at risk) are lethal.

Cutaneous inoculation listeriosis: Inoculation of the pathogen in veterinarians and agricultural workers (favoured by eczematous skin changes - occupational listeriosis). At the site of inoculation, formation of localized (grouped), painless, non-pruritic papulo-vesiculous, or pustular efflorescences, which may transform into small ulcers. I.A. uncomplicated self-limiting course.

Diagnosis
This section has been translated automatically.

Direct pathogen detection in throat swabs, skin lesions, meconium, perforations, stool. Antibody detection, intradermal test.

Differential diagnosis
This section has been translated automatically.

Complication(s)
This section has been translated automatically.

Listeria meningitis (lethality rate despite therapy approx. 30%).

Therapy
This section has been translated automatically.

  • Therapy of choice is ampicillin (e.g. Binotal) 6-12 g/day in 3-4 ED i.v. therapy over at least 3 weeks.
  • Alternatively Cotrimoxazol (e.g. Cotrimox Wolff): Dosage Trimethoprim/Sulfamethoxalzol: 20/100 mg/kg bw/day.
  • If necessary combinaton with gentamicin (e.g. Refobacin) 3-5 mg/kg bw/day i.v. or i.m. as 1 ED.

Notice! The duration of therapy should be at least 14 days due to the risk of recurrence.

Note(s)
This section has been translated automatically.

Named after the British surgeon Josef Baron Lister (1827-1912)

Literature
This section has been translated automatically.

  1. Asahata S et al (2015) Fournier's gangrene caused by Listeria monocytogenes as the primary organism. Can J Infect Dis Med Microbiol 26:44-46
  2. Braden CR (2003) Listeriosis. Pediatric Infect Dis J 22: 745-746
  3. Godshall CE et al (2013) Cutaneous listeriosis. J Clin Microbiol 51:3591-3596
  4. Paul ML et al (1994) Listeriosis - a review of eighty-four cases. Med J Aust 160: 489-493
  5. Perrin M et al (2003) Fatal case of Listeria innocua bacteremia. J Clin Microbiol 41: 5308-5309
  6. Vitas AI et al (2004) Occurrence of Listeria monocytogenes in fresh and processed foods in Navarra (Spain). Int J Food Microbiol 90: 349-356
  7. Vera-Kellet C et al (2014) Septic vasculitis caused by Listeria monocytogenes. Rev Chilena infectol 31:746-749
  8. Zelenik K et al (2014) Cutaneous listeriosis in a veterinarian with the evidence of zoonotic transmission--a case report. Zoonoses Public Health 61:238-241

Disclaimer

Please ask your physician for a reliable diagnosis. This website is only meant as a reference.

Authors

Last updated on: 25.04.2021